Bupivacaine Liposome (Exparel) — CPB 0941 | AETNA Coverage Update

Aetna modified CPB 0941 covering bupivacaine liposome (Exparel) billing, effective January 5, 2026. Here's what changes for billing teams.

Aetna, a CVS Health company, updated its Exparel coverage policy under CPB 0941 in the Aetna system, drawing a sharper line between covered indications and those it considers experimental or unproven. The policy covers CPT 64415 for interscalene brachial plexus nerve blocks and single-dose infiltration procedures — but denies coverage for 15 specific indications, from TAP blocks in colorectal surgery to peripheral nerve blocks for foot and ankle procedures. If your practice bills Exparel across a broad range of surgical pain management contexts, this policy tightens the fence considerably.

Quick-Reference Table

Aetna Bupivacaine Liposome (Exparel) Coverage Criteria and Medical Necessity Requirements 2026

The Aetna Exparel coverage policy covers four specific indications. Outside those four, Aetna treats the drug as experimental — and that's a hard denial, not a documentation problem you can fix after the fact.

Here are the four covered indications under CPB 0941:

Ultrasound guidance is covered with or without for all four indications. That matters for your charge capture — don't strip the ultrasound guidance code assuming it won't pass.

The medical necessity standard here is narrow. Aetna is not broadly approving Exparel for any nerve block your surgical team prefers. The clinical context has to match one of these four buckets exactly. If your anesthesiologist uses Exparel for a TAP block during a laparoscopic colectomy, that's not a documentation issue — it's a flat denial under this coverage policy.

Age matters too. The single-dose infiltration indication extends to pediatric patients 6 and older. The three nerve block indications are adults only. If you're billing Exparel nerve blocks for a 16-year-old, check your clinical documentation carefully.

Prior authorization requirements are not explicitly detailed in the CPB 0941 policy text itself — but given the number of experimental designations in this update, confirm your prior auth workflow with Aetna directly before scheduling high-cost Exparel cases outside the four covered indications. Reimbursement exposure on a denied Exparel claim is significant given the drug's cost.

Aetna Exparel Exclusions and Non-Covered Indications

This is where the policy gets expensive for teams that haven't been paying attention. Aetna lists 15 specific indications as experimental, investigational, or unproven under CPB 0941 — citing insufficient peer-reviewed evidence for each. These aren't soft exclusions. Aetna will deny claims for these indications.

The 15 excluded indications are:

The real issue here is scope. Several of these are common Exparel use cases in orthopedic, colorectal, and reconstructive practices. TAP blocks for colorectal surgery, infra-clavicular blocks for upper extremity ORIF, peri-articular injections for shoulder arthroplasty — these aren't fringe uses. Surgeons and anesthesiologists have been using Exparel for these indications routinely.

If your practice has been billing Exparel for any of these 15 indications under Aetna plans, expect denials. Pull your Aetna Exparel claims from the past 6 to 12 months and look hard at which indications you've been billing. The claim denial risk here is real and immediate after the January 5, 2026 effective date.

Coverage Indications at a Glance

Aetna Exparel Billing Guidelines and Action Items 2026

CPT, HCPCS, and ICD-10 Codes for Bupivacaine Liposome (Exparel) Under CPB 0941

Covered CPT Codes (When Selection Criteria Are Met)

Not Covered / Experimental CPT Codes

These codes appear in the policy data linked to experimental indications. Aetna does not cover Exparel when billed in these surgical contexts.

The policy data includes 788 total CPT codes — the full list spans fracture, arthroplasty, and reconstructive procedure codes tied to the experimental indications above. The codes shown here represent the distinct procedure groups identified in the policy data. Confirm the full code list against the source policy at CPB 0941 on Aetna's policy portal before updating your charge capture.

The policy data does not list specific HCPCS or ICD-10-CM codes with descriptions. The policy references 4 HCPCS codes and 10 ICD-10-CM codes — pull those directly from the Aetna CPB 0941 source document to get the complete billing guidelines picture.